Long-term safety of unopposed estrogen used by women surviving myocardial infarction : 14 year follow-up of the ESPRIT randomised controlled trial

Cherry, N.McNamee, R.Heagerty, A.Kitchener, H.Hannaford, P.2015-04-302015-04-302014-05Cherry, N, McNamee, R, Heagerty, A, Kitchener, H & Hannaford, P 2014, 'Long-term safety of unopposed estrogen used by women surviving myocardial infarction : 14 year follow-up of the ESPRIT randomised controlled trial', BJOG-An International Journal of Obstetrics and Gynaecology, vol. 121, no. 6, pp. 700-705. https://doi.org/10.1111/1471-0528.125981470-0328http://hdl.handle.net/2164/44786117248engSDG 3 - Good Health and Well-beingcancerestrogenrandomised controlled trialRG Gynecology and obstetricsRGLong-term safety of unopposed estrogen used by women surviving myocardial infarction : 14 year follow-up of the ESPRIT randomised controlled trialJournal article10.1111/1471-0528.125981216